Samrat Pharma

{
  "main_header": {
    "sid": 116063,
    "name": "Samrat Pharma",
    "stock_name": "Samrat Pharma",
    "full_name": "Samrat Pharmachem Ltd",
    "name_url": "stocks-analysis/samrat-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "207.10",
    "chg": -1.9,
    "chgp": "-0.91%",
    "dir": -1,
    "prev_price": "209.00",
    "mcapval": "66.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530125,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE103E01016",
    "curr_date": "Apr 10",
    "curr_time": "",
    "bse_nse_vol": "546 ",
    "exc_status": "Active",
    "traded_date": "Apr 10, 2026",
    "traded_date_str": "2026 04 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/samrat-pharma-116063-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-3941496",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SamratPharmache_mojoScore_3941496.png",
        "date": "2026-04-10 10:10:24",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-3923788",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SamratPharmache_mojoScore_3923788.png",
        "date": "2026-03-30 10:10:17",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 30 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Five Consecutive Losses Push Samrat Pharmachem Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-ltd-stock-hits-52-week-low-at-rs1944-3924033",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SamratPharmache_priceRelatedfactors_3924033.png",
        "date": "2026-03-30 09:53:39",
        "description": "For the fifth consecutive session, Samrat Pharmachem Ltd closed lower, hitting a fresh 52-week low of Rs 194.4 on 30 Mar 2026. This decline comes amid a broader market that has shown some resilience, underscoring the stock's persistent underperformance."
      },
      {
        "title": "Why is Samrat Pharmachem Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-samrat-pharmachem-ltd-fallingrising-3921083",
        "imagepath": "",
        "date": "2026-03-28 01:24:34",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Intraday Price Movements and Trading Dynamics</strong></p>\n<p>Despite opening the day with a positive gap of 3.63%, reaching an intraday high of ₹212.50, the stock reversed sharply to close near its lowest point of the day. The weighted average price indicates that a larger volume of shares traded closer to the day’s low, signalling selling pressure as the session progressed. This intraday volatility suggests that initial optimism was quickly overshadowed by bearish sentiment among investors.</p>\n<p><strong>Technical Indicators Point to Downtrend</strong></p>\n<p>Samrat Pharmachem is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment of moving averages below the stock price is a classic technical indicator of sus..."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-3893267",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SamratPharmache_mojoScore_3893267.png",
        "date": "2026-03-16 10:10:15",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-3873120",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SamratPharmache_mojoScore_3873120.png",
        "date": "2026-03-05 10:10:20",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-3850643",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SamratPharmache_mojoScore_3850643.png",
        "date": "2026-02-22 10:10:29",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Samrat Pharmachem Ltd Faces Sharp Valuation Reassessment Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-ltd-faces-sharp-valuation-reassessment-amid-market-pressure-3843094",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SamratPharmache_valuationdot_3843094.png",
        "date": "2026-02-17 08:00:10",
        "description": "Samrat Pharmachem Ltd has witnessed a significant shift in its valuation parameters, with key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios deteriorating sharply compared to historical averages and peer benchmarks. This change has coincided with a steep decline in the stock price, prompting a downgrade in its investment grade to Strong Sell by MarketsMOJO as of 19 Aug 2025."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-3830447",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SamratPharmache_mojoScore_3830447.png",
        "date": "2026-02-10 10:10:48",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 February 2026, providing investors with the latest insights into its performance and outlook."
      }
    ],
    "total": 5747,
    "sid": "116063",
    "stock_news_url": "https://www.marketsmojo.com/news/samrat-pharmachem-116063"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2026",
      "details": "Certificate u/r 74(5) for the quarter ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "07-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Samrat Pharmachem Ltd-</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24230GJ1992PLC017820</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>-</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Nishant Kankaria <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: contact@samratpharmachem.in</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Rajesh Mehta <br/> Designation: CFO <br/> EmailId: rajesh@samratpharmachem.com</div> </div> <div> <br/> Date: 07/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "30-Mar-2026",
      "details": "Crisil Limited has upgraded its rating to CRISIL BB/STABLE/ CRISILA4+",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "30 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Samrat Pharmachem Ltd has declared <strong>10%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Samrat Pharmachem Ltd is Rated Strong Sell

2026-04-10 10:10:24

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Samrat Pharmachem Ltd is Rated Strong Sell

2026-03-30 10:10:17

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 30 March 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Five Consecutive Losses Push Samrat Pharmachem Ltd to a New 52-Week Low

2026-03-30 09:53:39

For the fifth consecutive session, Samrat Pharmachem Ltd closed lower, hitting a fresh 52-week low of Rs 194.4 on 30 Mar 2026. This decline comes amid a broader market that has shown some resilience, underscoring the stock's persistent underperformance.

Read full news article

Why is Samrat Pharmachem Ltd falling/rising?

2026-03-28 01:24:34

Intraday Price Movements and Trading Dynamics

Despite opening the day with a positive gap of 3.63%, reaching an intraday high of ₹212.50, the stock reversed sharply to close near its lowest point of the day. The weighted average price indicates that a larger volume of shares traded closer to the day’s low, signalling selling pressure as the session progressed. This intraday volatility suggests that initial optimism was quickly overshadowed by bearish sentiment among investors.

Technical Indicators Point to Downtrend

Samrat Pharmachem is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment of moving averages below the stock price is a classic technical indicator of sus...

Read full news article

Samrat Pharmachem Ltd is Rated Strong Sell

2026-03-16 10:10:15

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Samrat Pharmachem Ltd is Rated Strong Sell

2026-03-05 10:10:20

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Samrat Pharmachem Ltd is Rated Strong Sell

2026-02-22 10:10:29

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Samrat Pharmachem Ltd Faces Sharp Valuation Reassessment Amid Market Pressure

2026-02-17 08:00:10

Samrat Pharmachem Ltd has witnessed a significant shift in its valuation parameters, with key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios deteriorating sharply compared to historical averages and peer benchmarks. This change has coincided with a steep decline in the stock price, prompting a downgrade in its investment grade to Strong Sell by MarketsMOJO as of 19 Aug 2025.

Read full news article

Samrat Pharmachem Ltd is Rated Strong Sell

2026-02-10 10:10:48

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 February 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

View All News